The International Osteoporosis Foundation (IOF) has honored Dr. Thierry Chevalley, Associate Professor at the Faculty of Medicine, University of Geneva, Switzerland, with the distinguished IOF President’s Award. This accolade is reserved for individuals who have made significant and sustained contributions to the IOF’s mission of enhancing bone, muscle, and joint health on a global scale. Presented during the Opening Session of the World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2026) in Prague, Czech Republic, this recognition underscores Dr. Chevalley’s pivotal role in advancing research and clinical practices aimed at mitigating skeletal disorders.
Professor Nicholas Harvey, IOF President, lauded Dr. Chevalley for his unwavering commitment to the Foundation’s initiatives. Harvey emphasized Chevalley’s leadership as Vice-Chair of the governance board of the Capture the Fracture® programme, an initiative dedicated to the reduction of fracture risks worldwide through systematic post-fracture care coordination. Dr. Chevalley’s extensive involvement in the IOF Committee of Scientific Advisors and various scientific programs has been instrumental in shaping contemporary osteoporosis research and preventive strategies, highlighting his influential position in the international bone health community.
Dr. Chevalley’s academic journey reflects a profound dedication to osteology and geriatric medicine. Earning his medical degree from the University of Lausanne, he pursued doctoral studies at the University of Geneva, focusing his research on calcium supplementation and its impact on bone mineral density and fracture incidence among elderly populations. This work illuminated critical aspects of nutritional interventions in osteoporosis management, providing evidence-based guidance for clinical recommendations targeting older adults at high risk of fractures.
Upon completing postdoctoral research at Loma Linda University in California, Dr. Chevalley joined Geneva University Hospitals, where he assumed key roles including Head of the Geriatrics Liaison Unit and Consulting Physician in Bone Diseases. His multidisciplinary expertise encompasses the intersection of geriatrics and metabolic bone diseases, enabling him to contribute significantly to patient-centered approaches in fracture prevention and osteoporosis care. His clinical insights have informed both regional and international protocols for managing bone fragility.
As an internationally recognized authority on osteoporosis, Dr. Chevalley contributes to multiple high-profile advisory boards, including the IOF Committee of Scientific Advisors and the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO). His vice-chair position within the Capture the Fracture® programme’s governance structure underscores his leadership in promoting fracture liaison services (FLS), a systematic approach aimed at identifying and managing patients after fragility fractures to prevent subsequent fractures.
In addition to his organizational roles, Dr. Chevalley is a vital contributor to scientific literature, serving as Associate Editor for prestigious journals such as Osteoporosis International and Archives of Osteoporosis. His publication record, with over 8,000 citations, spans a broad spectrum of topics including the efficacy of fracture liaison services, bone health across the lifespan, and the complex relationships between nutrition, growth, and aging in skeletal homeostasis. His research continues to influence both clinical practice and health policy aimed at reducing the burden of musculoskeletal diseases.
Dr. Chevalley has been particularly active in promoting the development and implementation of fracture liaison services in Switzerland, collaborating with the Swiss Association Against Osteoporosis (ASCO). These services represent a paradigm shift in secondary fracture prevention, focusing on coordinated care pathways that integrate orthopedic care with osteoporosis assessment and treatment. His advocacy helps bridge gaps between acute fracture care and long-term bone health management, aiming to reduce recurrent fracture rates and associated morbidity.
The recognition of Dr. Chevalley’s contributions at WCO-IOF-ESCEO 2026, the world’s largest annual congress dedicated to bone, muscle, and joint diseases, reaffirms the critical importance of translational science in musculoskeletal health. The congress serves as an essential platform where researchers and clinicians converge to disseminate cutting-edge clinical research and explore therapeutic advancements in conditions such as osteoporosis, osteoarthritis, sarcopenia, and rare skeletal disorders.
Through his work, Dr. Chevalley exemplifies the integration of clinical expertise, research excellence, and organizational leadership necessary to tackle the complex challenges posed by musculoskeletal diseases. His efforts resonate beyond academia, influencing healthcare delivery systems worldwide and encouraging multidisciplinary collaboration to improve patient outcomes through evidence-based interventions.
The award reflects not only past achievements but also Dr. Chevalley’s ongoing commitment to innovation in fracture prevention and skeletal health. His involvement with global initiatives, coupled with his focus on geriatric populations and metabolic bone disease, positions him at the forefront of developing strategies that address aging-related bone loss and fracture risk reduction.
The IOF President’s Award bestowed upon Dr. Thierry Chevalley acknowledges a career dedicated to enhancing the understanding and clinical management of bone diseases, particularly osteoporosis, which remains a significant public health challenge globally. His intricate understanding of the biological mechanisms underpinning bone fragility and his advocacy for integrated care services underpin efforts to reduce the incidence and impact of fractures worldwide.
As the global population ages, the importance of experts like Dr. Chevalley in guiding policy and clinical practice cannot be overstated. His scientific contributions and leadership continue to shape the future of musculoskeletal health, aiming toward a world where fractures and their debilitating consequences are significantly diminished through innovation, education, and coordinated healthcare delivery.
Subject of Research: Osteoporosis, fracture prevention, fracture liaison services, bone health in geriatrics, effects of calcium supplementation on bone density
Article Title: International Osteoporosis Foundation Honors Dr. Thierry Chevalley with IOF President’s Award for Advancing Global Bone Health
News Publication Date: April 16, 2026
Web References:
https://www.wco-iof-esceo.org/
https://www.osteoporosis.foundation/
Keywords: Osteoporosis, fracture prevention, geriatrics, bone health, fracture liaison services, calcium supplementation, metabolic bone disorders, musculoskeletal diseases, aging, IOF President’s Award, Capture the Fracture®, clinical research, osteoporosis management
Tags: Capture the Fracture program leadershipclinical practices in skeletal disordersfracture risk reduction strategiesgeriatric medicine and osteologyglobal bone health leadershipInternational Osteoporosis Foundation awardIOF President’s Award recipientmusculoskeletal disease preventionosteoporosis research advancementspost-fracture care coordinationUniversity of Geneva medical researchWorld Congress on Osteoporosis 2026
